Key Segments:
By Product Type
-
Syringes
-
Needle-Free Injectors
-
Microneedle Patches
-
Nasal Spray Devices
-
Others
By Route of Administration
-
Intramuscular
-
Intradermal
-
Subcutaneous
-
Intranasal
By End User
-
Hospitals
-
Clinics
-
Immunization Centers
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Becton, Dickinson and Company, PharmaJet, 3M, Sanofi, Antares Pharma, Terumo Corporation, Nipro Corporation, and SHL Medical.
Key opportunities include thermostable formulation development, cold-chain-independent delivery technology, and emerging-market manufacturing infrastructure expansion.
The market is driven by expanding immunization programs, needle-free technology innovation, and growing pharmacy-based vaccination access.
The Syringes segment dominated the Vaccine Delivery Devices Market, accounting for approximately 58% market share.
The North America region dominated the Vaccine Delivery Devices Market in 2025 with approximately 32.0% share, driven by advanced infrastructure and vaccination program expansion.
